Navigation Links
Aspreva in Medical News

Aspreva's plan of arrangement with Galenica completed

... VICTORIA, Jan. 3 /PRNewswire-FirstCall/ - aspreva Pharmaceuticals Corporation (NASDAQ: ASPV ; TSX: ...ian subsidiary, acquired all outstanding shares of aspreva for US$26.00 per share in cash. With the completion of the plan of arrangement, aspreva will delist its shares from the NASDAQ on January ...

Aspreva receives Investment Canada approval for acquisition by Galenica

... VICTORIA, Dec. 21 /PRNewswire-FirstCall/ - aspreva Pharmaceuticals Corporation (NASDAQ: ASPV ; TSX: ...olumbia Business Corporations Act, was approved by aspreva shareholders and optionholders at a special meetin...ver of the remaining conditions for the benefit of aspreva as specified in the Combination Agreement. The tra...

Aspreva receives final court approval for acquisition by Galenica

... VICTORIA, Dec. 18 /PRNewswire-FirstCall/ - aspreva Pharmaceuticals Corporation (NASDAQ: ASPV ; TSX: ...olumbia Business Corporations Act, was approved by aspreva shareholders and optionholders at a special meetin...rcular dated November 15, 2007, which was filed by aspreva on the Canadian SEDAR website at http://www.sedar...

Aspreva obtains shareholder approval for acquisition by Galenica

... VICTORIA, BC, Dec. 17 /PRNewswire-FirstCall/ - aspreva Pharmaceuticals Corporation (NASDAQ: ASPV ; TSX: ...in order to facilitate the proposed acquisition of aspreva by Galenica Group. Further details regarding the...rcular dated November 15, 2007, which was filed by aspreva on the Canadian SEDAR website at http://www.sedar...

S.L.E. Lupus Foundation Gala Raises Record $3.2 Million for Lupus

...tments for people with lupus and other long-neglected diseases. "The name aspreva is derived from the words aspirations, hopes, and dreams," said aspreva Executive Vice President of Global Pharmaceutical Operations, Rick Goulburn...

Aspreva Sends Materials for Special Meeting to be Held December 17

...enica VICTORIA, Nov. 23 /PRNewswire-FirstCall/ - aspreva Pharmaceuticals Corporation (NASDAQ: ASPV ; TSX: ...ith Galenica Group (SWX: GALN) have been mailed to aspreva shareholders and optionholders of record. Copies o...s has approved the Arrangement and recommends that aspreva shareholders vote in favor of the resolutions appr...

Aspreva to be Acquired by Galenica For US$915 Million

...are - VICTORIA, Oct. 17 /PRNewswire-FirstCall/ - aspreva Pharmaceuticals Corporation (NASDAQ: ASPV ; TSX: ...t premium over the 30-day average trading price of aspreva shares. aspreva will host a conference call on October 18th, 2007,...

Aspreva Announces Preliminary Revenues for Third Quarter 2007

... VICTORIA, Oct. 16 /PRNewswire-FirstCall/ - aspreva Pharmaceuticals Corporation (NASDAQ: ASPV ; TSX: ...e third quarter of 2006. As previously announced, aspreva will release its full financial results on Wednesd... and to provide a general corporate update. About aspreva Pharmaceuticals ...

Aspreva to Announce 2007 Third Quarter Results on October 31st

... VICTORIA, BC, Oct. 15 /PRNewswire-FirstCall/ - aspreva Pharmaceuticals Corporation (NASDAQ: ASPV ; TSX: ...ng September 30, 2007 on Wednesday, October 31st. aspreva will host a conference call to discuss results for...pany's fourth quarter 2007 conference call. About aspreva Pharmaceuticals ...

Clinical Trials for Lupus Underway After Decades of Drought

...org, has logged more than 14,000 visitors since it launched in late spring. The campaign is supported in part by unrestricted educational grants from aspreva Pharmaceuticals and Genentech/Biogen Idec. About Lupus LA Lupus LA is dedicated to supporting new science in lupus, and as a National Coalition memb...
Aspreva in Medical Technology

Lupus Foundation of America Statement on Results for Clinical Study of CellCept Released by Aspreva Pharmaceutical Company

Statement by Sandra C. Raymond, President & CEO of the Lupus Foundation of America, Inc. WASHINGTON, June 27, 2007 /PRNewswire-USNewswire/ -- The Lupus Foundation of America, Inc. and more than 1.5 million Americans with lupus have been awaiting the preliminary findings of the Phase III clinic...

Aspreva and Roche Announce Preliminary Results for Phase III Study Evaluating CellCept in Lupus Nephritis

...mine the potential for a regulatory submission and aspreva plans to present the final results at an appropria...erse events was comparable in both treatment arms. aspreva will host a conference call today at 9:30 a.m. ET ...e on a patient's quality of life. More About the aspreva Lupus Nephritis Study Aspreva's lupus nephritis ...
Aspreva in Biological Technology

Follica Appoints Drug Development and Dermatology Veteran, William D. Ju, as Chief Executive Officer

...TX, who bring together deep domain knowledge in life sciences and information technology. The firm's investments in life sciences include: ArthroCare, aspreva Pharmaceuticals Corporation (acquired by Galenica group, SWX: GALN), Cor Therapeutics (acquired by Millennium Pharmaceuticals), Corixa (acquired by Gl...

QED International Associates Announces Changes to the HealthShares(TM) Autoimmune-Inflammation and Neuroscience Indexes - Correction

...Pharmaceutical, Inc. (Nasdaq: ALXN ) will replace aspreva Pharmaceutical, Inc. (Nasdaq: ASPV ) in the Healt...ndex. Alpharma, Inc. (NYSE: ALO) will also replace aspreva Pharmaceutical, Inc. in the HealthShares(TM) Neuroscience Index. aspreva Pharmaceutical is being acquired by Galencia Group...

QED International Associates Announces Changes to the HealthShares(TM) Autoimmune-Inflammation and Neuroscience Indexes

... 2008, Maxygen, Inc. (Nasdaq: MAXY ) will replace aspreva Pharmaceutical, Inc. (Nasdaq: ASPV ) in the Healt...ex. Alpharma, Inc. (NYSE: ALO ) will also replace aspreva Pharmaceutical, Inc. in the HealthShares(TM) Neuroscience Index. aspreva Pharmaceutical is being acquired by Galencia Group...

Biotech Continues Upward Climb in October

...on clinical trials for its developmental drug, Telcyta, designed to treat advanced ovarian cancer and non-small cell lung cancer. Also jumping 24% was aspreva Pharmaceuticals, which has agreed to be acquired by Galenica for approximately $915 million. IPO's heat up again After a short lull, the appetite fo...

Financing of biotech companies so far in 2005: A Midwest odyssey

...window is still open. As seen above, only two of the companies had a share price above $10 per share, which is one indicator of IPO strength. aspreva Pharmaceuticals was the only company to have a significant amount of money raised (i.e. above $75 million). So what makes for a successful IPO? It is ...
Other Tags
(Date:7/28/2014)... According to the Greek God Muscle Building Program review ... that teaches men how to completely transform their physique by ... its review that inside the Greek God Muscle Building Program ... gain the maximum muscle fiber recovery , ... gain , Ways to incorporate the specialization routines ...
(Date:7/28/2014)... 28, 2014 To commemorate World Hepatitis ... of Living with a Disability magazine has ... disorders that include hepatitis, gastrointestinal hemorrhage, inflammatory bowel disease, ... important new article highlights that, in the context of ... hepatitis and other disabling conditions related to the digestive ...
(Date:7/28/2014)... 28, 2014 Greta Pontarelli, 63, won her ... Champion title at the World Pole Sports Championships in London ... this athlete. She is the only U.S. competitor to qualify, ... Pole Sports Federation (IPSF). Over 150 athletes ranging in age ... in the competition. Pontarelli scored first place in the Masters ...
(Date:7/27/2014)... 28, 2014 Zensah®, the leader in compression ... include a wrist support . The wrist support features ... area. , Lateral and Medial Epicondylitis, more commonly referred to ... which there is inflammation of the tendons attached to the ... wrist pain, the muscles that work the wrist and fingers ...
(Date:7/27/2014)... regimens could provide shorter, more effective treatment options with ... with hepatitis C, even those most difficult to treat, ... The Lancet . , Both studies focused on ... genotype in the USA, Europe, North Asia, Australia, and ... treat. , Around 150 million people worldwide have chronic ...
Breaking Medicine News(10 mins):Health News:Greek God Muscle Building Program Review Exposes Greg O’Gallagher's Muscle Building Guide for Men – Vkool.com 2Health News:Greek God Muscle Building Program Review Exposes Greg O’Gallagher's Muscle Building Guide for Men – Vkool.com 3Health News:Living with a Disability Magazine Marks World Hepatitis Day on July 28 with New Article on Disabling Digestive Disorders 2Health News:Living with a Disability Magazine Marks World Hepatitis Day on July 28 with New Article on Disabling Digestive Disorders 3Health News:Inspiring Senior Athlete Lands Third World Title in One Year 2Health News:Zensah® Releases New Wrist Support 2Health News:The Lancet: New oral drug regimens cure hardest-to-treat hepatitis C 2Health News:The Lancet: New oral drug regimens cure hardest-to-treat hepatitis C 3
(Date:7/25/2014)... 25 countries and 35 states will attend the ... Society of America (GSA) next week at the ... feature close to 500 presentations (including 70 talks) ... expression and regulation, functional genomics, chemical biology and ... variety of diseases. , Of special note ...
(Date:7/25/2014)... healthcare community and remain priority areas that ... the worldwide crisis of obesity and diabetes, ... in diabetes, epidemiology and public health describe ... of diverse intervention programs in this novel ... on "Global Health Perspectives in Prediabetes and ...
(Date:7/25/2014)... factor characterized by the existence of numerous isoforms ... to the protein deeply different characteristics. NRG1 plays ... during development and the different phases occurring after ... regrowth, remyelination and target reinnervation, Researchers at the ... soluble NRG1 upregulation observed in Schwann cells immediately ...
Breaking Biology News(10 mins):Yeast meeting to showcase latest breakthroughs in genetics and molecular biology 2What constitutes an effective response to the global 'diabesity' tsunami? 2
Other Contents